Benaroya Research Institute Receives $5.4 Million NIH Contract Award to Improve Treatment for Patients with Rheumatoid Arthritis
Read More
A New Clinical Trial on the Treatment of Multiple Sclerosis Starts Enrollment
Read news ➡
Life Science Washington Welcomes New Board Chair, Executive Committee Members, and Directors
Read More
Bills in Washington State Would Lower Price of Insulin, Other Prescriptions
Read More
BRI’s Immune Tolerance Network Launches BEAT-MS Clinical Trial for MS
Read More
Benaroya Research Institute Opens the Sound Life Project, A Research Study of Healthy Immune Systems
Read More
Type 1 Diabetes Discovery Opens Door to Game-Changing Treatment Strategies
Read More
Benaroya Research Institute Receives $4.5 Million Grant to Predict Which Cancer Patients will Benefit from Immunotherapy
Read More
An interview with Lauren Lippencott and Jane Buckner in the Winter 2019 Print Edition of Allergic Living Magazine
Inflammatory Bowel Diseases Are On The Rise – Why Is This Happening?
Learn more ➡
Groundbreaking Immunotherapy Can Delay Onset of Diabetes for 2 Years
Watch video ➡
Groundbreaking Immunotherapy Can Delay Onset of Diabetes for 2 Years
Read More
Discriminative T Cell Recognition of Cross-Reactive Islet-Antigens Is Associated with HLA-DQ8 Transdimer–Mediated Autoimmune Diabetes
Read news ➡
Anti-CD3 drug keeps diabetes at bay
Read Nature Biotechnology news ➡
